HCA Healthcare, Inc. (HCA)

HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, as well as rehabilitation and physical therapy centers, physician practices, home health agencies, hospices, outpatient physical therapy providers, home and community-based services providers, and various other facilities. Its general and acute care hospitals offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic services, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

Ticker
HCA
Exchange
NYSE
Sector
Healthcare
Industry
Medical Care Facilities
Market cap
$105.69B
52-week range
$353.99 - $556.52

Valuation

Share price
$476.35 (close of Nov 18, 2026)
P/E (TTM)
16.38x
Price to book
-22.98x
Price to free cash flow
17.69x
Enterprise value
$157.21B
Book value per share
$-21.81

Price performance

PeriodChange
1 day-4.96%
5 days-5.87%
1 month+3.82%
3 months+15.69%
6 months+12.67%
Year to date+2.03%
1 year-0.37%
3 years+93.34%
5 years+95.83%
10 years+558.03%
All time+1,435.62%

Short interest

As of
Oct 30, 2026
Short % of float
3.60%
Shares short
4.80M
Days to cover
3.31
Change since prior report
-2.14%
Source
FINRA consolidated short interest

Members of Congress who disclosed HCA trades

Jared Moskowitz · Lisa McClain · Val Hoyle · Alan Armstrong · Julie Johnson · Robert Bresnahan

Super investors holding HCA

First Eagle Investment (First Eagle Investment Management, LLC) · Ray Dalio (Bridgewater Associates) · Bill Nygren (Harris Associates LP) · First Pacific Advisors (First Pacific Advisors, LP) · Ken Griffin (Citadel) · Richard Pzena (Pzena Investment Management) · Glenn Greenberg (Brave Warrior Advisors, LLC) · Lee Ainslie (Maverick Capital LTD)

Profitability and growth

Return on invested capital
21.84%*
Return on assets
11.17%
Return on capital employed
27.23%*
Net margin
8.97%
EBITDA margin
19.32%
Revenue growth
7.08%
Net income growth
17.78%
Free cash flow growth
36.41%

* Estimated EBIT: pre-tax income + net interest. This company reports no operating income line.

Cash flow and balance sheet

Free cash flow yield (TTM)
5.65%
Current ratio
0.82x
Net debt to EBITDA
3.24x

Latest reported year

Period end
Dec 31, 2025
Fiscal year
2025
Revenue
$75.60B
EBITDA
$14.61B
Net income
$6.78B
Earnings per share
$28.70
Interest expense
$2.25B
Shares outstanding
236.41M

Income statement by year

Period endRevenueNet incomeEPS
2025-12-31$75.60B$6.78B$28.70
2024-12-31$70.60B$5.76B$22.27
2023-12-31$64.97B$5.24B$19.25
2022-12-31$60.23B$5.64B$19.43
2021-12-31$58.75B$6.96B$21.52
2020-12-31$51.53B$3.75B$11.10
2019-12-31$51.34B$3.50B$10.27
2018-12-31$46.68B$3.79B$10.90
2017-12-31$43.61B$2.22B$6.12
2016-12-31$41.49B$2.89B$7.53

Margins and returns by year

Period endNet marginReturn on equityReturn on capital
2025-12-318.97%-21.84%*
2024-12-318.16%-19.04%*
2023-12-318.07%-18.71%*
2022-12-319.37%-21.37%*
2021-12-3111.84%-23.85%*
2020-12-317.28%129.81%16.33%*
2019-12-316.83%-16.78%*
2018-12-318.11%-20.55%*
2017-12-315.08%-15.80%*
2016-12-316.97%-19.96%*

* Estimated EBIT: pre-tax income + net interest. This company reports no operating income line.

Cash and debt by year

Period endCashDebt
2025-12-31$1.04B$41.60B
2024-12-31$1.93B$38.33B
2023-12-31$935.00M$37.17B
2022-12-31$908.00M$37.71B
2021-12-31$1.45B$34.34B
2020-12-31$1.91B$30.80B
2019-12-31$768.00M$33.58B
2018-12-31$549.00M$32.03B
2017-12-31$786.00M$32.86B
2016-12-31$695.00M$31.16B

Free cash flow by year

Period endFree cash flowStock-based compensation
2025-12-31$7.69B$401.00M
2024-12-31$5.64B$360.00M
2023-12-31$4.69B$262.00M
2022-12-31$4.13B$341.00M
2021-12-31$5.38B$440.00M
2020-12-31$6.40B$362.00M
2019-12-31$3.44B$347.00M
2018-12-31$3.19B$268.00M
2017-12-31$2.41B$270.00M
2016-12-31$2.89B$251.00M

Dividend history

Most recent payment
Sep 16, 2026
Paid in the last twelve months
$3.06
Payment dateDividend per share
2026-09-16$0.78
2026-06-16$0.78
2026-03-17$0.78
2025-12-15$0.72
2025-09-16$0.72
2025-06-16$0.72
2025-03-17$0.72
2024-12-13$0.66

Investor relations

Past earnings dates

ReportedFiscal periodEPS estimate
2026-10-27Sep 2026$6.74
2026-07-24Jun 2026$7.57
2026-04-24Mar 2026$7.17
2026-01-27Dec 2025$7.36
2025-10-24Sep 2025$5.65
2025-07-25Jun 2025$6.19
2025-04-25Mar 2025$5.77
2025-01-24Dec 2024$5.97

Filings and sources

Company website
hcahealthcare.com
SEC filings
10-K, 10-Q and 8-K on EDGAR
Earnings calendar
All upcoming reports

Similar companies

DaVita Inc. (DVA) · Universal Health Services Inc (UHS) · HealthEquity, Inc. (HQY) · Veeva Systems Inc (VEEV) · Abbott Laboratories (ABT) · Molina Healthcare, Inc. (MOH) · Medtronic plc (MDT) · Centene Corp (CNC)

All Healthcare companies

Understanding these figures

Price-to-earnings ratio · Short interest · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart

Explore

Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades